KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Debt (2016 - 2025)

Biogen (BIIB) has 16 years of Total Debt data on record, last reported at $6.3 billion in Q4 2025.

  • For Q4 2025, Total Debt rose 38.26% year-over-year to $6.3 billion; the TTM value through Dec 2025 reached $6.3 billion, up 38.26%, while the annual FY2025 figure was $6.3 billion, 38.26% up from the prior year.
  • Total Debt reached $6.3 billion in Q4 2025 per BIIB's latest filing, up from $150.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $6.9 billion in Q4 2023 and bottomed at $150.0 million in Q2 2025.
  • Average Total Debt over 5 years is $4.2 billion, with a median of $5.4 billion recorded in 2022.
  • Peak YoY movement for Total Debt: skyrocketed 528.67% in 2022, then crashed 34.46% in 2024.
  • A 5-year view of Total Debt shows it stood at $999.1 million in 2021, then surged by 528.67% to $6.3 billion in 2022, then rose by 10.46% to $6.9 billion in 2023, then crashed by 34.46% to $4.5 billion in 2024, then soared by 38.26% to $6.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $6.3 billion in Q4 2025, $150.0 million in Q2 2025, and $4.5 billion in Q4 2024.